Pathologic stage IIB esophageal adenocarcinoma ajcc V8
Clinical trials for Pathologic stage IIB esophageal adenocarcinoma ajcc V8 explained in plain language.
Never miss a new study
Get alerted when new Pathologic stage IIB esophageal adenocarcinoma ajcc V8 trials appear
Sign up with your email to follow new studies for Pathologic stage IIB esophageal adenocarcinoma ajcc V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Virus therapy joins Chemo-Radiation in fight against esophageal cancer
Disease control OngoingThis early-phase trial tests whether adding a cancer-killing virus called OBP-301 to standard chemotherapy and radiation is safe for people with advanced esophageal or gastroesophageal cancer who cannot have surgery. The virus is designed to infect and destroy tumor cells. Sixtee…
Matched conditions: PATHOLOGIC STAGE IIB ESOPHAGEAL ADENOCARCINOMA AJCC V8
Phase 1 • Sponsor: NRG Oncology • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
New combo therapy before surgery shows promise for esophageal cancer
Disease control OngoingThis study is testing whether adding two immunotherapy drugs (atezolizumab and tiragolumab) to standard chemotherapy before surgery can help control esophageal or gastroesophageal cancer. About 43 adults with stage II or III cancer will receive the drug combination, then undergo …
Matched conditions: PATHOLOGIC STAGE IIB ESOPHAGEAL ADENOCARCINOMA AJCC V8
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Can a vaccine stop GI cancers from returning?
Prevention PausedResearchers are testing an experimental vaccine called Ad5.F35-hGCC-PADRE in adults who have had surgery and standard treatment for gastrointestinal cancers, including pancreatic, colorectal, esophageal, gastric, and small bowel adenocarcinomas. The trial aims to find a safe dose…
Matched conditions: PATHOLOGIC STAGE IIB ESOPHAGEAL ADENOCARCINOMA AJCC V8
Phase 2 • Sponsor: Thomas Jefferson University • Aim: Prevention
Last updated Sep 16, 2026 00:00 UTC